Gravar-mail: SCDT-43. BLOCKING OF INTERACTING CK2 AND EGFR PATHWAYS BY TUMOR-TARGETING NANOCONJUGATES INCREASES THERAPEUTIC EFFICACY AGAINST GLIOBLASTOMA MULTIFORME